Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 1SANOFI WINTHROP INDUSTRIE Gentilly FR
02 1DERIVADOS QUIMICOS S.A.U. Alcantarilla ES
03 1NOSCH LABS PRIVATE LIMITED Hyderabad IN
01 3Ciprofibrate
01 1France
02 1India
03 1Spain
01 3Valid
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Certificate Number : CEP 2011-120 - Rev 05
Status : Valid
Issue Date : 2024-04-17
Type : Chemical
Substance Number : 2013
Certificate Number : CEP 2013-112 - Rev 03
Status : Valid
Issue Date : 2024-05-03
Type : Chemical
Substance Number : 2013
Certificate Number : R0-CEP 2021-263 - Rev 00
Status : Valid
Issue Date : 2023-06-12
Type : Chemical
Substance Number : 2013
A Ciprofibrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ciprofibrate, including repackagers and relabelers. The FDA regulates Ciprofibrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ciprofibrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ciprofibrate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Ciprofibrate supplier is an individual or a company that provides Ciprofibrate active pharmaceutical ingredient (API) or Ciprofibrate finished formulations upon request. The Ciprofibrate suppliers may include Ciprofibrate API manufacturers, exporters, distributors and traders.
click here to find a list of Ciprofibrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Ciprofibrate CEP of the European Pharmacopoeia monograph is often referred to as a Ciprofibrate Certificate of Suitability (COS). The purpose of a Ciprofibrate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Ciprofibrate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Ciprofibrate to their clients by showing that a Ciprofibrate CEP has been issued for it. The manufacturer submits a Ciprofibrate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Ciprofibrate CEP holder for the record. Additionally, the data presented in the Ciprofibrate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Ciprofibrate DMF.
A Ciprofibrate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Ciprofibrate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Ciprofibrate suppliers with CEP (COS) on PharmaCompass.
We have 3 companies offering Ciprofibrate
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
